Comparing sensorimotor and neuromuscular training with Typical off season ice hockey training for ice hockey players
Official title: Sensorimotor Training to Enhance Performance - the STEP AHEAD Program
- 2 groups
- One site, in Calgary
- Recruiting
Interventions
- Other intervention
sensorimotor and neuromuscular training
Sensorimotor and neuromuscular training exercises aimed at training the cervical spine neuromuscular control, vestibular system and oculomotor system in addition to ice hockey specific training the incorporates higher level integrated functional activities of these integrated systems. This will be performed at the same frequency as their typical training - four days per week in the gym, one day of yoga or recovery as well as on ice sessions.
- Other intervention
Typical off season ice hockey training
Typical training for ice hockey players off season
Canadian Sites (1)
1 of 1 recruiting
- Recruiting
Concussion Rehabilitation Laboratory
Calgary, Alberta
Eligibility Criteria
See who this study is looking for1 criteria
The trial’s own eligibility text, word for word from the registry. Only the trial site can say who takes part.
Inclusion
- +Ice hockey players in Calgary and area who are training with Crash Conditioning for the 2024-2026 off season -
In plain language
Assembled directly from this trial’s registry record. Every sentence traces to a field below — nothing here is generated or interpreted.
What this study is
This study does not fall into the standard research categories.
This study is not organised into the usual phase numbers — that is common for device, behavioural, and diagnostic research.
From the trial registry
Built from these fields:
- designModule.designInfo.primaryPurpose
- designModule.phases
Who receives what
There are 2 groups in this study.
Group A receives sensorimotor and neuromuscular training, together with one or more of: Typical off season ice hockey training.
Registry label: A: Sensorimotor and neuromuscular training
Group B, the comparison group, receives Typical off season ice hockey training.
Registry label: B: Typical off season training
From the trial registry
Built from these fields:
- armsInterventionsModule.armGroups[].label
- armsInterventionsModule.armGroups[].type
- armsInterventionsModule.armGroups[].interventionNames
How the study is run
Groups are assigned by the study team using set rules, rather than by chance.
This study is open-labelOpen-labelEveryone knows which treatment is being given — nothing is hidden.Read more →: everyone knows which treatment is being given, including you and the study team.
From the trial registry
Built from these fields:
- designModule.designInfo.allocation
- designModule.designInfo.maskingInfo.masking
Is there a placebo?
This study does not list a placeboPlaceboA dummy treatment with no active medicine, used for comparison.Read more → group.
One group receives an existing treatment, so the two can be compared.
From the trial registry
Built from these fields:
- armsInterventionsModule.armGroups[].type
- armsInterventionsModule.armGroups[].interventionNames
Who the study is looking for
The study lists an age range of 12 years to 40 years.
The study is open to people of any sex.
The study does not accept healthy volunteersHealthy volunteerSomeone without the condition being studied who takes part anyway.Read more →.
These are the criteria the study lists. Only the trial siteTrial siteA hospital or clinic where a study is actually run.Read more → can decide whether someone can take part.
From the trial registry
Built from these fields:
- eligibilityModule.minimumAge
- eligibilityModule.maximumAge
- eligibilityModule.sex
- eligibilityModule.healthyVolunteers
How big and how long
The study aims to enrol about 250 people.
The study is currently expected to finish around July 2026.
The main measurement is taken over: 0 weeks, 4 weeks, 8 weeks each year, up to 2 years.
From the trial registry
Built from these fields:
- designModule.enrollmentInfo.count
- statusModule.completionDateStruct.date
- outcomesModule.primaryOutcomes[].timeFrame
What the study measures
Craniocervical flexion — measured over 0 weeks, 4 weeks, 8 weeks each year, up to 2 years.
Dynamic Visual Acuity — measured over 0 weeks, 4 weeks, 8 weeks each year, up to 2 years.
Vestibular Ocular Motor Screen (VOMS) — measured over 0 weeks, 4 weeks, 8 weeks each year, up to 2 years.
Advanced Functional Gait Assessment — measured over 0 weeks, 4 weeks, 8 weeks each year, up to 2 years.
The study lists 1 further main measurements.
From the trial registry
Built from these fields:
- outcomesModule.primaryOutcomes[].measure
- outcomesModule.primaryOutcomes[].timeFrame
Source: NCT07402746 on ClinicalTrials.gov. The full registry text is further down this page — this summary never replaces it.
Not medical advice. What do these terms mean?
What is being tested — in plain terms
About sensorimotor and neuromuscular trainingOther
Sensorimotor and neuromuscular training exercises aimed at training the cervical spine neuromuscular control, vestibular system and oculomotor system in addition to ice hockey specific training the incorporates higher level integrated functional activities of these integrated systems. This will be performed at the same frequency as their typical training - four days per week in the gym, one day of yoga or recovery as well as on ice sessions.
From the trial registry — its own words, unedited.
What a other is here: An intervention the registry did not place in another category.
Read the full explanation → · in clinical review
About Typical off season ice hockey trainingOther
Typical training for ice hockey players off season
From the trial registry — its own words, unedited.
What a other is here: An intervention the registry did not place in another category.
Read the full explanation → · in clinical review
Common questions
Answered from this trial’s registry record. Where the record doesn’t say, these answers say so rather than filling the gap.
Am I eligible for this trial?
Only the trial siteTrial siteA hospital or clinic where a study is actually run.Read more → can decide whether someone can take part. Concord cannot make that determination, and neither can any tool that has not examined you.
What the study lists: an age range of 12 years to 40 years.
The full inclusionInclusion criteriaThe things you must have or be for a study to consider you.Read more → and exclusion criteriaExclusion criteriaThe things that would prevent someone from taking part.Read more → are published on this page, exactly as the study team wrote them.
The useful next step is to bring this trial to your doctor. Answering a few questions first gives them something concrete to review.
From the trial registry
- eligibilityModule.minimumAge
- eligibilityModule.maximumAge
- eligibilityModule.eligibilityCriteria
Is there a placebo?
This study does not list a placeboPlaceboA dummy treatment with no active medicine, used for comparison.Read more → group.
One group receives an existing treatment so the two can be compared.
From the trial registry
- armsInterventionsModule.armGroups[].type
Would I know which treatment I am getting?
This study is open-labelOpen-labelEveryone knows which treatment is being given — nothing is hidden.Read more →: everyone knows which treatment is being given, including you and the study team.
Groups are assigned by the study team using set rules, rather than by chance.
From the trial registry
- designModule.designInfo.maskingInfo.masking
- designModule.designInfo.allocation
Who can join?
The study lists an age range of 12 years to 40 years.
It is open to people of any sex.
It does not accept healthy volunteersHealthy volunteerSomeone without the condition being studied who takes part anyway.Read more →.
Only the trial siteTrial siteA hospital or clinic where a study is actually run.Read more → can confirm whether a particular person can take part.
From the trial registry
- eligibilityModule.minimumAge
- eligibilityModule.maximumAge
- eligibilityModule.sex
- eligibilityModule.healthyVolunteers
How long would this take?
The study's main measurement is taken over: 0 weeks, 4 weeks, 8 weeks each year, up to 2 years.
The study as a whole is currently expected to finish around 2026-07.
How long any one person takes part can differ from the study length. The study team can tell you what the schedule looks like in practice.
From the trial registry
- outcomesModule.primaryOutcomes[].timeFrame
- statusModule.completionDateStruct.date
How many people are taking part?
The study aims to enrol about 250 people.
From the trial registry
- designModule.enrollmentInfo.count
Where is this happening?
This study lists one location: Calgary, Alberta, Canada.
Sites can open and close during a study, so confirm with the team before travelling.
From the trial registry
- trial_locations
About This Trial
The goal of this study is to evaluate the effects of SM/NM training in ice hockey players. The specific questions include: 1) typical performance on sensorimotor and neuromuscular (SM/NM) tests 2) evaluate SM/NM training on ice hockey skills performance and SM/NM tests, 3) evaluate SM/NM control to prevent concussions and injuries Participants will: Consent and complete a series of SM/NM tests. Participate in their typical training for 4 weeks. Repeat the SM/NM tests. Participate in SM/NM training for 4 weeks as part of their off season training program. Repeat the SM/NM tests and on ice skills testing. Record any injuries and concussions that they sustain over the next season. Repeat the SM/NM tests and on ice skills tests at the start of the 2025 off season training (estimated May - July of 2025).
Think this trial might be right for you?
Complete a quick intake form and we will match you with this and other relevant trials based on your medical profile.
See if this trial could fit youThis page is for informational purposes only and does not constitute medical advice. Clinical trial eligibility can only be determined by the trial site after proper screening. Trial information is sourced from ClinicalTrials.gov and may not reflect the most current status. Always consult your healthcare provider before making decisions about clinical trial participation.